Categories
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
751
Antibiotics
271
Bioactive Small Molecules
799
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
24
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
27
Water Analysis
13
Celecoxib
(70641057 | 169590-42-5)
CAS: | 169590-42-5 |
---|---|
Molecular Formula: | C17H14F3N3O2S |
Molecular Weight: | 381.37 |
Availablility: | In Stock |
---|---|
Downloads: | | |
This product is subject to a hazardous surcharge. The exact amount will be confirmed by our sales team.
70641057-25mg | 25mg | £143.90 | |
Bulk Order |
70641057-25mg | 25mg | €201.50 | |
Bulk Order |
70641057-25mg | 25mg | $215.90 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 70641057 | ||||
Product Name | Celecoxib | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 169590-42-5 | ||||
Molecular Formula | C17H14F3N3O2S | ||||
Molecular Weight | 381.37 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 2935909099 |
Product Specification
Assay/Purity | 98.0%-102.0% | ||||
Melting Point | 160℃-164℃ | ||||
Water | ≤0.5% | ||||
Total impurity | ≤0.5% | ||||
Heavy metals | ≤20ppm | ||||
Residue on Ignition | ≤0.2% | ||||
Appearance | White or almost white crystalline powder |
Safety Information
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|